Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A journey of 1000 miles begins with a single step-proteomics, hyperinflation, and chronic obstructive pulmonary disease.

Annals of the American Thoracic Society·2026
Same author

Digitally assessed home FEV<sub>1</sub> to identify the cause of poorly controlled asthma: a protocol paper for a prospective replicate cohort study.

BMJ open respiratory research·2025
Same author

Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering Approach.

The journal of allergy and clinical immunology. In practice·2025
Same author

Digital Assessment of Adherence to Asthma Inhalers in Primary Care, Is It Worth the Effort?

The journal of allergy and clinical immunology. In practice·2025
Same author

Do You Believe in Magic? Computed Tomography, Artificial Intelligence, and Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine·2025
Same author

Prediction Pathway for Severe Asthma Exacerbations: A Bayesian Network Analysis.

Chest·2025
Same journal

Prediction of therapeutic effect of antifibrotic therapy for idiopathic pulmonary fibrosis using quantitative CT texture analysis.

Respiratory medicine·2026
Same journal

Obesity and Early Sepsis-Associated Acute Respiratory Distress Syndrome: A Prospective Multicenter Study.

Respiratory medicine·2026
Same journal

Adults with Congenital Lung Malformations: A Descriptive Analysis of an Underexplored Population.

Respiratory medicine·2026
Same journal

Risk Factors and Microbiological Characteristics of Ventilator-Associated Pneumonia in a Tunisian Intensive Care Unit During the COVID-19 Pandemic.

Respiratory medicine·2026
Same journal

Impact of Therapeutic Hypothermia on Oxygen Demand and Respiratory Function in Post-Cardiac Arrest Patients: A Retrospective Cohort Study.

Respiratory medicine·2026
Same journal

The longitudinal decrease in exercise tolerance and disease progression in mild-to-moderate COPD.

Respiratory medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

Lung function changes following methacholine inhalation in COPD.

Paul P Walker1, Justine Hadcroft, Richard W Costello

  • 1Division of Infection and Immunity, School of Clinical Sciences, University of Liverpool, University Hospital Aintree, Liverpool, UK. ppwalker@liv.ac.uk

Respiratory Medicine
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

In severe COPD, methacholine challenge causes reduced lung volumes, not increased airway resistance, impacting forced expiratory volume in 1 second (FEV1). This suggests airway closure and expiratory flow limitation contribute to FEV1 decline in COPD patients.

More Related Videos

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
08:44

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Published on: February 2, 2024

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
13:10

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique

Published on: May 15, 2013

Related Experiment Videos

Last Updated: Jun 27, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
08:44

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Published on: February 2, 2024

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
13:10

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique

Published on: May 15, 2013

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology

Background:

  • Bronchial hyper-responsiveness in COPD is often linked to reduced airway caliber.
  • This study investigates the mechanisms behind FEV1 decline in severe COPD during methacholine challenge.

Purpose of the Study:

  • To determine if FEV1 decline in severe COPD is due to increased airway resistance or changes in lung volumes.
  • To compare the response to methacholine in severe COPD patients versus asthmatic subjects.

Main Methods:

  • Spirometry and oscillatory mechanics were measured in 25 moderate to severe COPD patients and 10 asthmatics.
  • Measurements were taken before and after methacholine challenge, at a 20% fall in FEV1 (PC(20)FEV1).

Main Results:

  • In COPD patients, methacholine challenge led to significant decreases in FVC, SVC, and IC, with no change in FEV1/FVC ratio or TLC.
  • Total respiratory system resistance remained unchanged, but reactance decreased significantly in COPD subjects.
  • Asthmatics showed increased obstruction, with a smaller lung volume fall and increased R(5).

Conclusions:

  • Methacholine-induced FEV1 fall in moderate to severe COPD is primarily driven by increased residual volume.
  • These changes in lung volumes may indicate airway closure and new expiratory flow limitation.
  • COPD and asthma exhibit distinct responses to methacholine challenge, highlighting different pathophysiological mechanisms.